Kangmei Pharmaceutical Co., Ltd. (600518)
Market Open
10 Aug, 06:57
SSE SSE Primary ¥
1. 36
+0.02
+1.4925%
¥
29.53B Market Cap
- P/E Ratio
0.1% Div Yield
128.34M Volume
- Eps
¥ 1.34
Previous Close Want to track 600518 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
600518 trading today higher at ¥1.36, an increase of 1.4925% from yesterday's close, completing a monthly increase of 12.3967% or ¥0.15. Over the past 12 months, 600518 stock lost -29.1667%.
600518 is not paying dividends to its shareholders.
The last earnings report, released on May 08, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.1143%, based on the last three reports.
Kangmei Pharmaceutical Co., Ltd. has completed 7 stock splits, with the recent split occurring on Jun 16, 2015.
The company's stock is traded on one exchange.
600518 Chart
People also search for
Kangmei Pharmaceutical Co., Ltd. (600518) FAQ
What is the stock price today?
The current price is ¥1.36.
On which exchange is it traded?
Kangmei Pharmaceutical Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 600518.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.1%.
What is its market cap?
As of today, the market cap is 29.53B.
Has Kangmei Pharmaceutical Co., Ltd. ever had a stock split?
Kangmei Pharmaceutical Co., Ltd. had 7 splits and the recent split was on Jun 16, 2015.
Kangmei Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Guowei Liu CEO | SSE Exchange | CNE0000017M1 ISIN |
| CN Country | 4,409 Employees | 28 Aug 2019 Last Dividend | 6 Jan 2011 Last Split | 19 Mar 2001 IPO Date |
Overview
Kangmei Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, primarily focused on the production and distribution of Chinese herbal medicines. Founded in 1997, the company has established a strong foothold in China's medical sector. Operating from its headquarters in Shenzhen, China, Kangmei Pharmaceutical expands its healthcare footprint through the operation of hospitals and pharmacies, along with the production of chemical medicines and health food. This diversified approach allows Kangmei to cater to a broad spectrum of healthcare needs, reinforcing its position in the healthcare market of China.
Products and Services
- Chinese Herbal Medicines - Kangmei Pharmaceutical specializes in the production of Chinese herbal medicines, utilizing traditional techniques and ingredients to offer natural therapeutic options. These medicines cater to a variety of ailments, providing alternatives to modern chemical medicines.
- Chemical Medicines - In addition to herbal medicines, the company also produces chemical medicines. This segment includes a range of pharmaceutical products developed through modern scientific research, aimed at treating diverse health conditions effectively.
- Health Food - Recognizing the importance of preventative healthcare, Kangmei offers health food products. These products are designed to support overall health and well-being, complementing the company’s medicinal offerings.
- Hospitals and Pharmacies Operation - Beyond manufacturing, Kangmei Pharmaceutical extends its expertise to the operation of hospitals and pharmacies. This allows for an integrated healthcare experience, enabling direct access to Kangmei’s range of products and services, while also providing comprehensive medical care.
Contact Information
Address: Taike Road, Shenzhen, China, 518000
Phone: 86 755 3318 7777
Website: https://www.kangmei.com.cn
